Medical technology firm Hologic has announced the commercial launch of its new Genius Digital Diagnostics System in Europe.
Combining deep learning-based artificial intelligence (AI) with advanced volumetric imaging technolog, the next generation system has been developed for the cervical cancer screening.
The Genius Digital Diagnostics System includes Genius Digital Imager to acquire images, Genius Cervical AI algorithm to analyse images, Genius Image Management Server (IMS) to store images and Genius Review Station to review case.
By narrowing tens of thousands of cells down to an AI-generated gallery, the new Genius Cervical AI algorithm enables to provide critical information to healthcare providers to guide early detection and enhanced treatment decisions for the patients.
Hologic international strategic development diagnostics vice president Andrew Pieprzyk said: “We strive to develop innovative solutions that meet our customers’ needs. We are delighted in the overwhelming positive feedback from the customers who have been the first in the world to use this technology.
“The technology enhances the capabilities of individual laboratories and also has the potential to radically transform how cervical cancer screening is carried out, by enabling laboratories within the same network to collaborate across the world to manage the case load.”
Designed with an aim of eliminating cervical cancer, the Genius Digital Diagnostics System will help detect pre-cancerous lesions and cervical cancer cells in women.
With the Genius Digital Diagnostics System, the image analysis evaluates every cell on a ThinPrep Pap test image to curate a single view of the clinically relevant objects.
To connect pathologists with remote review capabilities, the Genius Digital Diagnostics System facilitates collaboration across laboratories within a network.
Hologic is also coordination with major European laboratories such as Germany’s ZotzKlimas Diagnostics Laboratories for the assessment of the new system.
Last month, Hologic agreed to acquire US-based energy vessel sealing surgical devices provider Bolder Surgical for around $160m.
